New Zealand's Medsafe to strengthen GCP framework
This article was originally published in SRA
Executive Summary
New Zealand’s healthcare products regulatory agency, Medsafe, has proposed new measures to strengthen the country’s good clinical practice regulatory, legal and ethical framework1,2.
You may also be interested in...
India Proposes Tiered Approach To Oversee Genome Editing
India has proposed three categories for grouping genetically edited organisms based on the complexity of modifications.
UK's MHRA Looks Beyond Brexit Transition Period
Now that the UK has left the EU, the UK’s medicines regulator says it will use the rest of this year to work out how best to ensure continuity of drug regulation after the Brexit transition period ends on 31 December.
UK MHRA Looks Beyond Brexit Transition
Now that the UK has left the EU, the UK’s medicines regulator says it will use the rest of this year to work out how best to ensure continuity of drug regulation after the Brexit transition period ends on 31 December.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: